prikaz prve stranice dokumenta Donor-specific antibodies require preactivated immune system to harm renal transplant
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Izvorni znanstveni rad
Donor-specific antibodies require preactivated immune system to harm renal transplant
EBioMedicine, 9 (2016); 366-371. https://doi.org/10.1016/j.ebiom.2016.06.006
Süsal, Caner; ...; ...; ...; ...; ...; ...; ...; ...; Balen, Sanja; Živčić-Ćosić, Stela; ...; ...; ...; ...; ...; ...; ...; ...; ...; ...; ...; ...; Opelz, Gerhard Više autora...

Institucijski repozitorij: Repozitorij Medicinskog fakulteta u Rijeci

Citirajte ovaj rad

Süsal, C., Balen, S., Živčić Ćosić, S. i Opelz, G. (2016). Donor-specific antibodies require preactivated immune system to harm renal transplant. EBioMedicine, 9., 366-371. doi: 10.1016/j.ebiom.2016.06.006

Süsal, Caner, et al. "Donor-specific antibodies require preactivated immune system to harm renal transplant." EBioMedicine, vol. 9, 2016, str. 366-371. https://doi.org/10.1016/j.ebiom.2016.06.006

Süsal, Caner, Sanja Balen, Stela Živčić Ćosić i Gerhard Opelz. "Donor-specific antibodies require preactivated immune system to harm renal transplant." EBioMedicine 9 (2016): 366-371. https://doi.org/10.1016/j.ebiom.2016.06.006

Süsal, C., et al. (2016) 'Donor-specific antibodies require preactivated immune system to harm renal transplant', EBioMedicine, 9, str. 366-371. doi: 10.1016/j.ebiom.2016.06.006

Süsal C, Balen S, Živčić Ćosić S, Opelz G. Donor-specific antibodies require preactivated immune system to harm renal transplant. EBioMedicine [Internet]. 2016. [pristupljeno 25.12.2024.];9:366-371. doi: 10.1016/j.ebiom.2016.06.006

C. Süsal, S. Balen, S. Živčić Ćosić i G. Opelz, "Donor-specific antibodies require preactivated immune system to harm renal transplant", EBioMedicine, vol. 9, str. 366-371, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:445418. [Citirano: 25.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:445418
Podaci o radu
Naslov (engleski)Donor-specific antibodies require preactivated immune system to harm renal transplant
AutorCaner Süsal
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
AutorSanja Balen
MBZ: 236875
AutorStela Živčić-Ćosić
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
Autor
...
AutorGerhard Opelz
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za kliničko-laboratorijsku dijagnostiku)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Klinička imunologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Background It is an unresolved issue why some kidney transplant recipients with pretransplant donor-specific HLA antibodies (DSA) show a high transplant failure rate, whereas in other patients DSA do not harm the graft. We investigated whether help from preactivated T-cells might be necessary for DSA to exert a deleterious effect. Methods The impact of pretransplant DSA and immune activation marker soluble CD30 (sCD30) on 3-year graft survival was analyzed in 385 presensitized kidney transplant recipients. Findings A deleterious influence of pretransplant DSA on graft survival was evident only in patients who were positive for the immune activation marker sCD30. In the absence of sCD30 positivity, 3-year graft survival was virtually identical in patients with or without DSA (83·1±3·9% and 84·3±2·8%, P=0·81). A strikingly lower 3-year graft survival rate of 62·1±6·4% was observed in patients who were both sCD30 and DSA positive (HR 2·92, P<0·001). Even in the presence of strong DSA with ≥5, 000 MFI, the 3-year graft survival rate was high if the recipients were sCD30 negative. Interpretation Pretransplant DSA have a significantly deleterious impact on graft survival only in the presence of high pretransplant levels of the activation marker sCD30.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaEBioMedicine
Brojčani podacivol. 9, str. 366-371
p-ISSN2352-3964
DOIhttps://doi.org/10.1016/j.ebiom.2016.06.006
URN:NBNurn:nbn:hr:184:445418
Datum objave publikacije2016
URL dokumentahttp://bib.irb.hr/820647
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-02-17 09:27:45